LFG
TNGX icon

Larson Financial Group’s Tango Therapeutics TNGX Stock Holding History

Larson Financial Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.82K Hold
250
– – ﹤0.01% 2548
2026
Q1 		$5.23K Buy
250
+216
+635% +$3.01K ﹤0.01% 2585
2025
Q4 		$301 Buy
+34
New +$293 ﹤0.01% 3211

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Larson Financial Group's TNGX Position: Q2 2026 in Review

Larson Financial Group held its Tango Therapeutics (TNGX) position steady in Q2 2026 at 250 shares worth $7.82K. The position accounts for ﹤0.01% of the portfolio, ranked #2548.

Larson Financial Group first reported a position in TNGX in Q4 2025 and has held it in 3 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Larson Financial Group held 250 shares of Tango Therapeutics worth $7.82K as of Q2 2026.
  • Larson Financial Group left its Tango Therapeutics share count unchanged in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2548 holding.
  • Larson Financial Group first reported a position in Tango Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.